School personnel information

写真b

SHIMAMURA Munehisa


Date of Birth

1973.01

Keyword

brain infarction, cerebral ischemia, cerebral vasculardisorders, Parkinson's Disease

Mail Address

Mail Address

Laboratory Phone number

+81-6-6210-8359

Laboratory Fax number

+81-6-6210-8360

URL

http://www.cgt.med.osaka-u.ac.jp/vme/greeting.html

Gender

Male

Organization 【 display / non-display

  • 2009.06.01 - 2010.03.31, Division of Internal Medicine, Graduate School of Medicine, Assistant Professor

  • 2010.04.01 - 2015.03.31, United Graduate School of Child Development, Associate Professor

  • 2015.04.01 - , Graduate School of Medicine, Associate Professor

Education 【 display / non-display

Osaka University Graduate School, Division of Medical Sciences  Completed 2005.03

Employment Record 【 display / non-display

Department of Neurology, Graduate School of Medicine, Kumamoto University 1997.04 - 2003.01
Department of Advanced Clinical Science and Therapeutics, Graduate School of Medicine, the University of Tokyo 2005.04 - 2007.03
Division of Neurobiology, Weill Cornell Medical College pot-doctoral fellow 2007.03 - 2009.04
Department of Geriatric Medicine and Nephrology, Osaka University Graduate School of Medicine 2009.05 - 2010.03
Division of Vascular Medicine and Epigenetics,Osaka University, Kanazawa University and Hamamatsu University School of Medicine, Associate Professor 2010.04 - 2015.03

Research topics 【 display / non-display

  • Neurology-related, Neurosurgery-related

  • Neurology-related

Academic Society Membership 【 display / non-display

  • American Stroke Association

  • Society for Neuroscience

 

Academic Papers 【 display / non-display

  • Analysis of PEG-J associated complications in 14 adult patients treated with levodopa-carbidopa intestinal gel, Shimamura M, Shinzaki S, Ikenaka K, Konaka K, Hirozawa D, Ishikura T, Hideshima M, Nakano T, Kitano T, Takehara T, Mochizuki H, Rinsho Shinkeigaku,59(3) 153-156, 2019.02, Papers

  • Therapeutic Vaccine Against S100A9 (S100 Calcium-Binding Protein A9) Inhibits Thrombosis Without Increasing the Risk of Bleeding in Ischemic Stroke in Mice, Kawano T, Shimamura M, Nakagami H, Iso T, Koriyama H, Takeda S, Baba K, Sasaki T, Sakaguchi M, Morishita R, Mochizuki H, Hypertension,72(6) 1355-1364, 2018.12, Papers

  • Therapeutic Vaccine Against S100A9 (S100 Calcium-Binding Protein A9) Inhibits Thrombosis Without Increasing the Risk of Bleeding in Ischemic Stroke in Mice., Kawano T, Shimamura M, Nakagami H, Iso T, Koriyama H, Takeda S, Baba K, Sasaki T, Sakaguchi M, Morishita R, Mochizuki H, Hypertension,72(6):1355-1364, 2018.12, Papers

  • Development of a novel RANKL-based peptide, microglial healing peptide1-AcN (MHP1-AcN), for treatment of ischemic stroke., Shimamura M, Nakagami H, Shimizu H, Mukai H, Watanabe R, Okuzono T, Kawano T, Ikeda Y, Hayashi H, Yoshida S, Ju N, Mochizuki H, Morishita R, Sci Rep,8(1):17770, 2018.12, Papers

  • Therapeutic Effects of Systemic Administration of the Novel RANKL-Modified Peptide, MHP1, for Ischemic Stroke in Mice, Shimamura M, Nakagami H, Shimizu H, Wakayama K, Kawano T, Ikeda Y, Hayashi H, Yoshida S, Mochizuki H, Morishita R, BioMed Research International,2018 4637084, 2018.07, Papers

display all >>